Health insurer Centene, a major provider of individual coverage under the Affordable Care Act (ACA), made a surprising announcement on Tuesday when it withdrew its 2025 guidance due to lower than expected market growth in more than 20 states. This decision has caused concern among investors and has raised questions about the company’s future performance.
According to a statement released by Centene, an independent actuarial firm’s analysis in 22 states where the company sells individual coverage on the ACA marketplaces revealed that the overall market growth was lower than anticipated. The analysis also showed a higher aggregate market morbidity than what was previously assumed by Centene, leading to a significant impact on the company’s risk adjustment revenue transfer.
The analysis, conducted by Wakely, covered 22 out of the 29 states where Centene operates and represents approximately 72% of the company’s marketplace membership. As a result of this analysis, Centene’s net risk adjustment revenue transfer expectation is estimated to decrease by around $1.8 billion, with a corresponding adjusted diluted EPS impact of approximately $2.75.
Despite experiencing a 29% increase in enrollment in Obamacare plans in the first quarter of this year, adding over 1 million members, Centene has faced challenges with a decrease in Medicaid coverage for low-income Americans. The company’s expansion into new markets for 2025 helped offset some of these losses, but the unexpected market trends have put additional strain on Centene’s financial outlook.
In response to the recent developments, Centene is in the process of analyzing data for the second quarter of 2025 and plans to report its results on July 25. The company also anticipates further reductions in its net risk adjustment revenue transfer expectation for the remaining seven states where it sells Obamacare plans.
The timing of Centene’s announcement coincides with the passing of a budget bill by the U.S. Senate, which could have further implications for the company and other Medicaid providers. The legislation, if approved by the U.S. House of Representatives, is expected to result in millions of Americans losing health insurance coverage, primarily affecting those enrolled in Obamacare plans and Medicaid coverage for low-income individuals.
As Centene navigates these challenges and prepares for the future, investors and industry experts will be closely monitoring the company’s performance and strategic decisions in the coming months. The impact of these recent developments on Centene’s overall business operations and financial health remains to be seen.
